Mercado mundial de isótopos de braquiterapia: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado de isótopos de braquiterapia

Según la agencia internacional para la investigación sobre el cáncer (IARC), se espera que el número de pacientes con cáncer alcance alrededor de 24,6 millones para 2030. Se estima que alrededor de 19,3 millones de nuevos casos serán diagnosticados como casos de cáncer en 2020 y 10 millones de muertes registradas en 2020. Uno de los principales factores que impulsan la expansión del mercado es el creciente uso de la braquiterapia por parte de los médicos para tratar una variedad de neoplasias malignas, incluidas las de próstata, piel, mama, estómago, cuello uterino, cerebro, cuello y pulmón, entre otras. Se anticipa que la creciente adopción de cirugías mínimamente invasivas, un aumento en el número de pacientes con cáncer en todo el mundo y un aumento en la demanda de tratamiento del cáncer en sus primeras etapas impulsarán el crecimiento del mercado durante el período de pronóstico. También se anticipa que la braquiterapia verá avances tecnológicos crecientes. La eficacia de la braquiterapia en el tratamiento del cáncer, su alto grado de precisión y su alta probabilidad de curar con éxito el cáncer contribuyen al crecimiento del mercado.

Data Bridge Market Research analiza que el mercado de isótopos de braquiterapia, que fue de USD 785 millones en 2021, se disparará hasta USD 1182,98 millones para 2029, y se espera que experimente una CAGR del 5,26% durante el período de pronóstico de 2022 a 2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis de expertos en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance y segmentación       del mercado de isótopos de braquiterapia

Definición de mercado

Radioterapia interna, también conocida como braquiterapia. Es un tipo de radioterapia en la que la radiación se aplica directamente al tumor canceroso en el cuerpo desde una fuente que se ha implantado cerca. La fuente produce rayos gamma, que se concentran en las células cancerosas para minimizar el daño al tejido sano circundante. Dependiendo de la gravedad de la enfermedad y el daño que cause, se utilizan dosis bajas (LDR) o dosis altas (HDR) de braquiterapia. En la LDR, se implantan pequeñas semillas radiactivas de forma permanente dentro o alrededor del tumor, pero en la HDR, que se utiliza en situaciones de tumores de alto riesgo, las fuentes radiactivas se eliminan del cuerpo del paciente al final de cada sesión.

Dinámica del mercado de isótopos de braquiterapia

Conductores

• Aumento del uso de radiofármacos con fines terapéuticos

El aumento de los niveles de financiación para el desarrollo de tecnología de vanguardia, el uso creciente de radiofármacos y la adopción de diversos tratamientos y diagnósticos son algunos de los factores que se prevé que impulsen el crecimiento del mercado de isótopos de braquiterapia durante el período proyectado de 2022 a 2029.

• Demanda creciente de isótopos de braquiterapia

Por otra parte, la creciente demanda de isótopos de braquiterapia en las regiones emergentes combinada con el aumento de la fabricación de radiofármacos creará una serie de perspectivas favorables a lo largo del período de pronóstico.

• Avances tecnológicos

The market growth has also been significantly boosted by technological developments in oncology therapies and considerable research and development (R&D), such as trials for treating neovascular age-related macular degeneration. The market is also being considerably driven by expanding medical tourism around the world, as well as increased knowledge of the benefits of brachytherapy, its cost-effectiveness, and its rising cure rate when compared to surgery or external beam therapy (EBT).

Opportunities

• Increase in the number of research and development activities 

The market's growth is fuelled by as increased knowledge of the benefits of brachytherapy, its cost-effectiveness, and its rising cure rate when compared to surgery or external beam therapy (EBT). This will provide beneficial opportunities for the market growth.

Restraints/Challenges

• High cost

On the other hand, the high cost along with reduced supply of isotopes, lack of skilled professionals will obstruct the market's growth rate.

However, the possibility of side effects to the area being treated and the availability of alternative cancer treatment methods are major restraining factors that could hamper the growth of the market.

This brachytherapy isotopes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the brachytherapy isotopes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Brachytherapy Isotopes Market

A global economic crisis was brought on by the 2019 coronavirus disease (COVID-19), particularly in the healthcare industry. Due to the COVID-19 pandemic's suspension of exports and imports, there are now shortages of resources. Due to the disease's susceptibility to spread in the current situation, surgical operations are avoided, which results in a loss of revenue. Since March, the COVID-19 pandemic has had a negative effect on the brachytherapy isotopes, causing income to decline by 50% to 70%. There are a lot of tiny hospitals and nursing homes that must close. Additionally, visa cancellations have halted medical tourism and may have a detrimental effect on the expansion of the healthcare services business.

Global Brachytherapy Isotopes Market Scope

The brachytherapy isotopes market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Iodine (I-125)
• Cesium (Cs-131)
• Iridium (Ir-192)
• Palladium (Pd-103)
• Others

 Application

• Prostate Cancer
• Thyroid Cancer
• Liver Cancer
• Gastro-Entero-Pancreatic-Neuroendocrine Tumors
• Metastatic Bone Cancer
• Breast Cancer
• Others

End-User

• Hospitals
• Ambulatory Centers
• Diagnostic Centers
• Others

Brachytherapy Isotopes Market Regional Analysis/Insights

The brachytherapy isotopes market is analysed and market size insights and trends are provided by country, type, application and end user as referenced above.

The countries covered in the brachytherapy isotopes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the brachytherapy isotopes market due to the prevalence of improved healthcare reforms and healthcare system.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the increasing occurrences of cancer and adoption of advanced technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Brachytherapy Isotopes Market Share Analysis

The brachytherapy isotopes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to brachytherapy isotopes market.

Algunos de los principales actores que operan en el mercado de isótopos de braquiterapia son:

• Bayer AG (Alemania)
• GENERAL ELECTRIC (EE.UU.)
• Cardinal Health (Estados Unidos)
• Jubilant Life Sciences Ltd (India)
• Lantheus (Estados Unidos)
• Novartis AG (Suiza)
• Siemens (Alemania)
• Isoray Inc. (Estados Unidos)
• Eckert & Ziegler (Alemania)
• iCAD Inc. (Estados Unidos)
• Servicios Transcend (Estados Unidos)
• Transcripción médica global LLC (EE. UU.)
• nThrive Revenue Systems, LLC (Estados Unidos)
• CareCloud, Inc. (Estados Unidos)
• MediScript (India)
• Transtech Medical Solutions LLC (Estados Unidos)

SKU-53695